Ribosomopathy-associated mutations cause proteotoxic stress that is alleviated by TOR inhibition
More about Open Access at the CrickAuthors list
Carles Recasens Alvarez Cyrille Alexandre Joanna Kirkpatrick Hisashi Nojima David J Huels Bram Snijders Jean-Paul VincentAbstract
Ribosomes are multicomponent molecular machines that synthesize all of the proteins of living cells. Most of the genes that encode the protein components of ribosomes are therefore essential. A reduction in gene dosage is often viable albeit deleterious and is associated with human syndromes, which are collectively known as ribosomopathies1-3. The cell biological basis of these pathologies has remained unclear. Here, we model human ribosomopathies in Drosophila and find widespread apoptosis and cellular stress in the resulting animals. This is not caused by insufficient protein synthesis, as reasonably expected. Instead, ribosomal protein deficiency elicits proteotoxic stress, which we suggest is caused by the accumulation of misfolded proteins that overwhelm the protein degradation machinery. We find that dampening the integrated stress response4 or autophagy increases the harm inflicted by ribosomal protein deficiency, suggesting that these activities could be cytoprotective. Inhibition of TOR activity-which decreases ribosomal protein production, slows down protein synthesis and stimulates autophagy5-reduces proteotoxic stress in our ribosomopathy model. Interventions that stimulate autophagy, combined with means of boosting protein quality control, could form the basis of a therapeutic strategy for this class of diseases.
Journal details
Journal Nature Cell Biology
Volume 23
Issue number 2
Pages 127-135
Available online
Publication date
Full text links
Publisher website (DOI) 10.1038/s41556-020-00626-1
Europe PubMed Central 33495632
Pubmed 33495632
Keywords
Related topics
Type of publication